Insiders Updates
A Guide To The Risks Of Investing In Atossa Therapeutics Inc (ATOS)
Atossa Therapeutics Inc’s recent filing unveils that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0
Menu
Atossa Therapeutics Inc’s recent filing unveils that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Atossa Therapeutics Inc’s filing revealed that its Director Remmel H. Lawrence acquired Company’s shares for reported $7000.0 on Mar 26
Atossa Therapeutics Inc. (NASDAQ:ATOS) does about 563.52K shares in volume on a normal day but saw 206077 shares change hands